Patents Assigned to NORDIC NANOVECTOR AS
  • Method for upregulating antigen expression
    Patent number: 10646599
    Abstract: The present invention relates to radioimmunoconjugates that are capable of upregulating expression of one or more antigens. The upregulated antigens can be the antigens that are targeted by the radioimmunoconjugates or different antigens expressed on the same cells. The present invention also relates to methods of treating cancer and diseases and disorders of the immune system by utilizing this enhanced expression of antigens.
    Type: Grant
    Filed: June 13, 2018
    Date of Patent: May 12, 2020
    Assignee: NORDIC NANOVECTOR ASA
    Inventors: Roy H. Larsen, Ada Repetto-Llamazares
  • Radioimunoconjugates and uses thereof
    Patent number: 9358309
    Abstract: The present invention relates to a radioimmunoconjugate that binds human CD37. Pharmaceutical compositions and uses thereof for the treatment of cancer and in particular B cell malignancies are aspects of the present invention.
    Type: Grant
    Filed: December 9, 2013
    Date of Patent: June 7, 2016
    Assignee: Nordic Nanovector AS
    Inventors: Roy H. Larsen, Jostein Dahle, Øyvind S. Bruland
  • RADIOIMMUNOCONJUGATES AND USES THEREOF
    Publication number: 20140147384
    Abstract: The present invention relates to a radioimmunoconjugate that binds human CD37. Pharmaceutical compositions and uses thereof for the treatment of cancer and in particular B cell malignancies are aspects of the present invention.
    Type: Application
    Filed: December 9, 2013
    Publication date: May 29, 2014
    Applicant: Nordic Nanovector AS
    Inventors: Roy H. Larsen, Jostein Dahle, Øyvind S. Bruland
  • Radioimmunoconjugates and uses thereof
    Patent number: 8628749
    Abstract: The present invention relates to a radioimmunoconjugate that binds human CD37. Pharmaceutical compositions and uses thereof for the treatment of cancer—and in particular B-cell malignancies—are aspects of the present invention.
    Type: Grant
    Filed: January 28, 2011
    Date of Patent: January 14, 2014
    Assignee: Nordic Nanovector AS
    Inventors: Roy H. Larsen, Jostein Dahle, Øyvind S Bruland
  • RADIOIMMUNOCONJUGATES AND USES THEREOF
    Publication number: 20120301396
    Abstract: The present invention relates to a radioimmunoconjugate that binds human CD37. Pharmaceutical compositions and uses thereof for the treatment of cancer—and in particular B-cell malignancies—are aspects of the present invention.
    Type: Application
    Filed: January 28, 2011
    Publication date: November 29, 2012
    Applicant: NORDIC NANOVECTOR AS
    Inventors: Roy H. Larsen, Jostein Dahle, Øyvind S. Bruland